462 filings
Page 12 of 24
6-K
CLLS
Cellectis S.A.
6 Jul 20
Cellectis Reports Clinical Hold Placed on MELANI-01 Study
4:50pm
6-K
CLLS
Cellectis S.A.
30 Jun 20
Current report (foreign)
7:45am
6-K
CLLS
Cellectis S.A.
29 Jun 20
Current report (foreign)
12:00am
6-K
CLLS
Cellectis S.A.
25 Jun 20
Current report (foreign)
4:30pm
F-3ASR
CLLS
Cellectis S.A.
2 Jun 20
Automatic shelf registration (foreign)
4:17pm
6-K
CLLS
Cellectis S.A.
18 May 20
Cellectis Appoints Biopharma Veteran Leopold Bertea as Senior Vice President of Technical Operations - Europe
5:00pm
6-K
CLLS
Cellectis S.A.
8 May 20
Current report (foreign)
4:30pm
6-K
CLLS
Cellectis S.A.
6 May 20
Current report (foreign)
4:30pm
6-K
CLLS
Cellectis S.A.
6 May 20
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2020
4:30pm
6-K
CLLS
Cellectis S.A.
29 Apr 20
Current report (foreign)
4:30pm
6-K
CLLS
Cellectis S.A.
13 Apr 20
Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer
4:44pm
6-K
CLLS
Cellectis S.A.
10 Mar 20
Following Series of US and European Patent Grants, Cellectis Strengthens its Intellectual Property on CRISPR-Edited T-cell Therapies
4:31pm
20-F
2019 FY
CLLS
Cellectis S.A.
Annual report (foreign)
5 Mar 20
12:00am
6-K
CLLS
Cellectis S.A.
4 Mar 20
Cellectis S.a. 6-K
5:02pm
6-K
CLLS
Cellectis S.A.
4 Mar 20
Cellectis S.a. 6-K
4:05pm
6-K
CLLS
Cellectis S.A.
25 Feb 20
Cellectis S.a. 6-K
4:30pm
6-K
CLLS
Cellectis S.A.
18 Feb 20
Cellectis S.a. 6-K
4:31pm
SC 13G
CLLS
Cellectis S.A.
14 Feb 20
Beneficial ownership report
12:07pm
SC 13G/A
CLLS
Cellectis S.A.
7 Feb 20
Beneficial ownership report (amended)
12:00am
6-K
CLLS
Cellectis S.A.
15 Jan 20
Cellectis S.a. 6-K
4:31pm